Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant - Archive ouverte HAL

New interface

Documentation
French (FR)

English (EN)

Journal Articles British Journal of Haematology Year : 2021

Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant

(1) , (1) , (2) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (2, 1) , (2, 1)

1
2

Amandine Le Bourgeois

Function : Author

Centre hospitalier universitaire de Nantes

Marianne Coste‐burel

Function : Author

Centre hospitalier universitaire de Nantes

Thierry Guillaume

Function : Author
PersonId : 766700
ORCID : 0000-0001-5482-8565

Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications

Pierre Peterlin

Function : Author
PersonId : 776625
ORCID : 0000-0001-5463-6686

Centre hospitalier universitaire de Nantes

Alice Garnier

Function : Author

Centre hospitalier universitaire de Nantes

Berthe‐marie Imbert

Function : Author

Centre hospitalier universitaire de Nantes

Thomas Drumel

Function : Author

Centre hospitalier universitaire de Nantes

Beatrice Mahé

Function : Author

Centre hospitalier universitaire de Nantes

Viviane Dubruille

Function : Author

Centre hospitalier universitaire de Nantes

Nicolas Blin

Function : Author

Centre hospitalier universitaire de Nantes

Anne Lok

Function : Author

Centre hospitalier universitaire de Nantes

Cyrille Touzeau

Function : Author
PersonId : 778761
ORCID : 0000-0003-0275-2575

Centre hospitalier universitaire de Nantes

Thomas Gastinne

Function : Author

Centre hospitalier universitaire de Nantes

Benoît Tessoulin

Function : Author
PersonId : 1040919
ORCID : 0000-0001-7600-3329
IdRef : 195047265

Centre hospitalier universitaire de Nantes

Maxime Jullien

Function : Author
PersonId : 808174
ORCID : 0000-0001-6915-6570

Centre hospitalier universitaire de Nantes

Sophie Vantyghem

Function : Author

Centre hospitalier universitaire de Nantes

Philippe Moreau

Function : Author
PersonId : 759214
ORCID : 0000-0003-1780-8746

Centre hospitalier universitaire de Nantes

Steven Le Gouill

Function : Author
PersonId : 761203
ORCID : 0000-0001-9840-2128

Centre hospitalier universitaire de Nantes

Marie Béné

Function : Author
PersonId : 767851
ORCID : 0000-0002-6569-7414

Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications

Centre hospitalier universitaire de Nantes

Patrice Chevallier

Function : Author
PersonId : 762210
ORCID : 0000-0003-3142-5581

Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications

Centre hospitalier universitaire de Nantes

Abstract

No abstract available

Keywords

BNT162b2 allogeneic haematopoietic stem cell transplantation coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) mRNA third dose vaccine

Domains

Life Sciences [q-bio] Cancer

Embargoed file

Embargoed file

Ne sera jamais visible

Elizabeth Bernardo : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-03542571

Submitted on : Tuesday, January 25, 2022-2:09:47 PM

Last modification on : Wednesday, November 23, 2022-6:10:04 PM

Long-term archiving on: Tuesday, April 26, 2022-6:54:53 PM

Dates and versions

inserm-03542571 , version 1 (25-01-2022)

Identifiers

HAL Id : inserm-03542571 , version 1
DOI : 10.1111/bjh.17911
PUBMED : 34671982
PUBMEDCENTRAL : PMC8653164

Cite

Amandine Le Bourgeois, Marianne Coste‐burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, et al.. Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant. British Journal of Haematology, 2021, pp.10.1111/bjh.17911. ⟨10.1111/bjh.17911⟩. ⟨inserm-03542571⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES CNRS UNIV-ANGERS CRCINA NANTES-UNIVERSITE

14 View

1 Download

Altmetric

Share